TFG Advisers’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,405
Closed -$242K 210
2024
Q3
$242K Hold
1,405
0.09% 191
2024
Q2
$216K Sell
1,405
-733
-34% -$110K 0.08% 188
2024
Q1
$329K Sell
2,138
-80
-4% -$12.2K 0.13% 152
2023
Q4
$351K Sell
2,218
-304
-12% -$43.7K 0.15% 143
2023
Q3
$369K Sell
2,522
-468
-16% -$71.3K 0.17% 133
2023
Q2
$458K Sell
2,990
-95
-3% -$14.8K 0.21% 118
2023
Q1
$478K Sell
3,085
-30
-1% -$4.71K 0.23% 108
2022
Q4
$480K Sell
3,115
-242
-7% -$35.7K 0.25% 107
2022
Q3
$443K Sell
3,357
-216
-6% -$30.3K 0.25% 101
2022
Q2
$484K Sell
3,573
-200
-5% -$27.6K 0.26% 102
2022
Q1
$563K Sell
3,773
-63
-2% -$9.32K 0.26% 103
2021
Q4
$621K Sell
3,836
-220
-5% -$35.6K 0.27% 100
2021
Q3
$674K Sell
4,056
-16
-0.4% -$2.73K 0.33% 88
2021
Q2
$703K Sell
4,072
-21
-0.5% -$3.47K 0.34% 85
2021
Q1
$657K Sell
4,093
-321
-7% -$55K 0.34% 83
2020
Q4
$741K Buy
4,414
+37
+0.8% +$6K 0.39% 76
2020
Q3
$688K Hold
4,377
0.4% 74
2020
Q2
$734K Sell
4,377
-17
-0.4% -$2.67K 0.48% 67
2020
Q1
$576K Sell
4,394
-2
-0% -$285 0.46% 70
2019
Q4
$653K Sell
4,396
-472
-10% -$64.8K 0.37% 77
2019
Q3
$602K Sell
4,868
-141
-3% -$18.8K 0.4% 79
2019
Q2
$705K Sell
5,009
-188
-4% -$25.9K 0.48% 73
2019
Q1
$784K Sell
5,197
-4
-0.1% -$576 0.57% 66
2018
Q4
$646K Buy
+5,201
New +$711K 0.54% 66

Other funds holding FBT

TFG Advisers's FBT Position: Q4 2024 in Review

TFG Advisers sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2024, closing a stake of 1,405 shares — an estimated $242K sold.

TFG Advisers first reported a position in FBT in Q4 2018 and held it in 24 quarters. The position peaked at $784K in Q1 2019. 256 funds tracked by Wall St. Rank hold FBT as of Q4 2024.

  • TFG Advisers reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2024 after selling out during the quarter.
  • TFG Advisers sold 1,405 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2024, an estimated $242K.
  • TFG Advisers first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and held it in 24 quarters.
  • TFG Advisers's First Trust NYSE Arca Biotechnology Index Fund position peaked at $784K in Q1 2019.
  • 256 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2024.

Based on TFG Advisers's 13F filing for Q4 2024, filed 28 Jan 2025.